Back to resultsA Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
Primary Purpose
Diabetes Mellitus
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
diabetes education via telemedicine
diabetes education in-person
Sponsored by
About this trial
This is an interventional treatment trial for Diabetes Mellitus focused on measuring Diabetes Education, Telemedicine
Eligibility Criteria
Inclusion Criteria:
- Type 1 or type 2 diabetes mellitus
- age > 18 years
Exclusion Criteria:
- Profound vision loss
- Severe hearing impairment
Sites / Locations
- Joslin Diabetes Center Affiliate at SUNY Upstate Medical University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
1
2
Arm Description
This arm will receive diabetes education via telemedicine
diabetes education in-person
Outcomes
Primary Outcome Measures
A1c
Secondary Outcome Measures
PAID scale
Diabetes Treatment Satisfaction Questionnaire
Full Information
NCT ID
NCT00629434
First Posted
February 25, 2008
Last Updated
October 5, 2021
Sponsor
State University of New York - Upstate Medical University
1. Study Identification
Unique Protocol Identification Number
NCT00629434
Brief Title
A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
Official Title
A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Terminated
Study Start Date
June 2001 (undefined)
Primary Completion Date
June 2008 (Actual)
Study Completion Date
August 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
State University of New York - Upstate Medical University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study compares group diabetes education in-person versus via telemedicine
Detailed Description
Diabetes education is important in the treatment of the person with diabetes. A diabetes self-management education program not only educates the patient and his/her family to the basics of diabetes care but also integrates diabetes care into daily life while providing coping skills to adjust to this chronic illness. Unfortunately, comprehensive diabetes care is not available to all persons with diabetes. One obstacle to the provision of comprehensive diabetes care is the unavailability of a diabetes treatment center. many people with diabetes live too far or do not have the transportation to be able to attend education programs that met national standards. We have shown that telemedicine is an effective means to provide comprehensive 1:1 individualized diabetes education to persons with diabetes. We now propose to test the hypothesis that diabetes groups education classes can be provided effectively through telemedicine technology to individuals living in rural areas. Patients with diabetes will received diabetes education via teleconferencing from our Joslin Diabetes center. The participants will be assessed before and after diabetes education via telemedicine using measures of glycemia (A1c) and assessments of patient satisfaction, emotional well being, and behavioral change and compared to results from participants attending our diabetes education classes in-person.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus
Keywords
Diabetes Education, Telemedicine
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
68 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
This arm will receive diabetes education via telemedicine
Arm Title
2
Arm Type
Active Comparator
Arm Description
diabetes education in-person
Intervention Type
Other
Intervention Name(s)
diabetes education via telemedicine
Intervention Description
This arm will receive diabetes group education via telemedicine
Intervention Type
Other
Intervention Name(s)
diabetes education in-person
Intervention Description
In this arm the group of patients with diabetes will receive diabetes education in-person
Primary Outcome Measure Information:
Title
A1c
Time Frame
baseline, 3 mo post intervention, 6 mo post intervention
Secondary Outcome Measure Information:
Title
PAID scale
Time Frame
baseline, 3 and 6 months post intervention
Title
Diabetes Treatment Satisfaction Questionnaire
Time Frame
Baseline, 3 and 6 months post intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Type 1 or type 2 diabetes mellitus
age > 18 years
Exclusion Criteria:
Profound vision loss
Severe hearing impairment
Facility Information:
Facility Name
Joslin Diabetes Center Affiliate at SUNY Upstate Medical University
City
Syracuse
State/Province
New York
ZIP/Postal Code
13214
Country
United States
12. IPD Sharing Statement
Learn more about this trial
A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
We'll reach out to this number within 24 hrs